TrialPath
Recruiting

FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control

NCT07332741 · University of Illinois at Chicago
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

About this study
FIM+DASH is adapted from the FIM+DASH pilot and informed by prior NIH-funded dietary interventions integrating clinic-community partnerships for culinary skill building and home food delivery. The intervention is designed to strengthen clinic-to-community linkages that support adoption and maintenance of a DASH eating pattern and hypertension (HTN) self-management for weight and BP control. Core components include in-person group and on-demand culinary skill-building, group and on-demand didactic content for DASH adoption and adherence and HTN self-management, brief one-on-one check-ins with a nutrition professional, and weekly DASH-friendly home food delivery.
Eligibility criteria
Inclusion Criteria: * Adults aged ≥18 years; diagnosis of hypertension in Electronic health record or most recent clinic blood pressure meeting inclusion thresholds (systolic blood pressure ≥130 mmHg and/or diastolic blood pressure ≥80 mmHg); BMI ≥30 kg/m²; able and willing to complete survey instruments and assessment procedures; able to speak/read English; access to a smartphone with text-messaging capability. Exclusion Criteria: * inability to speak/read English; cognitive impairment that precludes informed consent or participation; severe food allergies or medically necessary dietary restrictions that would preclude adoption of a DASH eating pattern; inability to cook at home; current treatment for cancer; self-reported history of a recent major cardiovascular event within the past 12 months (myocardial infarction, cerebrovascular accident, cardiac surgery, or hypertensive emergency); known advanced liver or renal disease; severe mental illness that would preclude participation; pregnancy. Individuals with lactose intolerance will not be excluded because low-lactose alternatives are available within the intervention.
Study design
Enrollment target: 150 participants
Allocation: randomized
Masking: single
Age groups: child, adult, older_adult
Timeline
Starts: 2026-05-22
Estimated completion: 2030-09
Last updated: 2026-07-10
Interventions
Combination Product: FIM intervention armCombination Product: FIM Usual Care Arm
Primary outcomes
  • Systolic and diastolic changes from baseline to 12 weeks and 24 weeks (Baseline, 12 weeks and 24 weeks)
Sponsor
University of Illinois at Chicago · other
All locations (4)
Mile Square Health Center ChicagoNot Yet Recruiting
Chicago, Illinois, United States
Mile Square Health Center - Auburn GreshamNot Yet Recruiting
Chicago, Illinois, United States
Mile Square Health Center - EnglewoodNot Yet Recruiting
Chicago, Illinois, United States
Mile Square Health Center - South ShoreRecruiting
Chicago, Illinois, United States
FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control · TrialPath